Business: Johnson & Johnson to buy Aragon for up to $1 billion

Source: Reuters

- Last modified: June 17, 2013 at 9:22 AM

Back to Top Comments Email Print

(Reuters) - Johnson & Johnson said on Monday that it would buy Aragon Pharmaceuticals, a private company that is running a mid-stage clinical trial for a prostate cancer drug, for $650 million in cash upfront and a possible second payment of $350 million if it meets certain milestones.

Continue reading



Be the first to comment.

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
Back to Top